NCT06244173

Brief Summary

The aim of our study is to assess clinical \& laboratory parameters of adult Egyptian myelodysplastic syndrome patients in upper Egypt, its correlation with disease-free survival, overall survival (OS) and acute leukemia transformation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
6.3 years until next milestone

First Submitted

Initial submission to the registry

October 4, 2023

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

6.4 years

First QC Date

October 4, 2023

Last Update Submit

February 5, 2024

Conditions

Myelodysplastic Syndromes

Outcome Measures

Primary Outcomes (1)

  • overall survival

    analysis of collected data

    baseline

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

cases of Denovo MDS attending to Sohag Univeristy hospital and Assuit University hospitals

You may qualify if:

  • De novo MDS according to WHO criteria diagnosis 2016

You may not qualify if:

  • MDS on top of AML

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag univeristy hospitals

Sohag, 82524, Egypt

Location

MeSH Terms

Conditions

Myelodysplastic Syndromes

Condition Hierarchy (Ancestors)

Bone Marrow DiseasesHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Asmaa abdelbaset, MD

    faculty of medicine - Sohag university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of internal medecine

Study Record Dates

First Submitted

October 4, 2023

First Posted

February 6, 2024

Study Start

June 1, 2017

Primary Completion

November 1, 2023

Study Completion

December 1, 2023

Last Updated

February 6, 2024

Record last verified: 2024-02

Locations

EG(1)